Langerhans Cell Histiocytosis
- 1 January 2012
- journal article
- case report
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 16 (1), 45-49
- https://doi.org/10.1177/120347541201600109
Abstract
Background: The cutaneous presentation of Langerhans cell histiocytosis (LCH) is very rare and can be highly variable among individuals, which can often lead to a delay in diagnosis. Objective: To discuss a case report and literature review of important clinical indicators, histology, diagnosis, evaluation, and treatment guidelines. Methods: Case report and literature review. Results: Skin biopsies positive for CD1a and/or langerin are diagnostic for LCH. A thorough review of systems, baseline laboratory tests, and imaging studies can determine the extent of LCH. Treatment of cutaneous disease is largely based on case report and small case studies, but baseline treatment should generally begin with oral or topical steroids. When patients have more severe disease that requires a systemic approach, the efficacy of therapy should be assessed 6 weeks into therapy, with subsequent treatment intensification in patients with limited response. Conclusion: Owing to the rarity of this condition, there are no specific guidelines for treatment of LCH, but guidelines put forth by the Histiocyte Society assist in categorization and basic treatment approaches for patients with systemic disease.Keywords
This publication has 17 references indexed in Scilit:
- Comparison of FDG‐PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosisPediatric Blood & Cancer, 2008
- Excimer Laser as Adjuvant Therapy for Adult Cutaneous Langerhans Cell HistiocytosisArchives of Dermatology, 2008
- Immunohistochemical Expression of Langerin in Langerhans Cell Histiocytosis and Non-Langerhans Cell Histiocytic DisordersThe American Journal of Surgical Pathology, 2008
- Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensificationBlood, 2008
- Adult cutaneous Langerhans cell histiocytosis responsive to topical imiquimodJournal of the American Academy of Dermatology, 2006
- Adult Langerhans cell histiocytosisEuropean Journal of Haematology, 2006
- A phase II trial using thalidomide for Langerhans cell histiocytosisPediatric Blood & Cancer, 2005
- Drug therapy for the treatment of Langerhans cell histiocytosisExpert Opinion on Pharmacotherapy, 2005
- Langerin (CD207) Staining in Normal Pediatric Tissues, Reactive LymphNodes, and Childhood Histiocytic DisordersPediatric and Developmental Pathology, 2004
- Histiocytosis X presenting as intertrigo and responding to topical nitrogen mustardClinical and Experimental Dermatology, 1986